digital health companies glp-1 programs Technologies enabling long-term outcomes for users Celebrity influence drives GLP-1 demand

Inhibition of DPPIV by NVP DPP728 improves metabolic control over a 4 week period in type 2 diabetes

In June 2023, Lilly announced that Retatrutide achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight and a mean weight reduction up to 24.2% at 48 weeks during phase II studies

Methods Computational analysis of human thyroid cancers in the cancer genome atlas database (TCGA) We queried the TCGA database of PTCs utilizing the Firehouse web browser from the Broad Institute ( and utilized TIMER2.0 ( a publicly available computational software, for analyses of tumor clinical and genomic features 35

Haynes BF, et al

The main barriers are access and cost

Translational study proposing a novel proteomic signature to diagnose ICP